Many of the issues associated with liver disease impact either the care we provide to our patients or lead to renal impairment. This session reviews the obstacles in CKD care that can occur with the various forms of liver diseases and outlines the care of the individual with hepatitis, including medical management of this disease. In addition, the disease of hyperoxaluria, its incidence, diagnosis, and treatment options provide another piece of the puzzle. The last facet to this ""connection"" concerns hepato-renal failure and interventions to care in both the acute and chronic stages of disease management.
Contact hours available until 4/24/2015
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure:
Kristin Larson – Consultant, Nephrology Clinical Solutions; Employee, Affymax; Other financial support, Kristin M. Larson, RN, MSN, LLC; Sandy Bodin – Employee, Affymax; Dawn Koonkongsatian – Employee, Fresenius Medical Care; Elizabeth St. John - Employee, Fresenius Medical Care
Presenter(s): Norah Terrault – Consultant, Bristol Myers Squibb, Merck, Siemens; Grant Support, Eisai, Novartis; Grant Support/Consultant, Abbott, Bitotest, Genentech, Gilead, Roche, Vertex
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Non-Endorsement of Products:
Accreditation of activities for contact hours does not imply approval or endorsement of any product, advertising, or educational content by ANNA or the American Nurses Credentialing Center’s Commission on Accreditation.
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
• Describe the anatomy and physiology of the hepatic system
• Compare and contrast the types of hepatitis seen in the patient with CKD.
• Describe expected disease progression in the various types of hepatitis
• Outline the differential diagnosis, work up and monitoring of the CKD patient with hepatitis
• List pharmacologic and non-pharmacologic interventions in the care of the patient with hepatitis
• Outline the specifics of hepatitis treatment and management in relationship to the patient with CKD including dialysis and transplantation.
• Illustrate an innovative plan of care for the management of hepatitis.
You must be logged in and own this session in order to post comments.